Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Translational evaluation of BUB1B as a precision medicine biomarker for hepatocellular carcinoma. | Sci Rep | 2026 | 41545558 | PubTator, text mining | PubMed |
| The MEK-RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers. | Nat Cancer | 2026 | 41482524 | PubTator, text mining | PubMed |
| CALR accelerates the growth of liver cancer cells by enhancing telomere activity via ARAF. | Genes Dis | 2026 | 41262532 | PubTator, text mining | PubMed |
| Upregulation of RAF and RalGDS gene expression by TGF-β in systemic sclerosis dermal fibroblasts: a controlled in vitro study. | Clin Rheumatol | 2026 | 41193890 | PubTator, text mining | PubMed |
| Rosai-Dorfman Disease With Novel BRAF Fusion Involving the Central Nervous System. | Int J Surg Pathol | 2026 | 40831220 | PubTator, text mining | PubMed |
| RAF isoform selectivity of MEK inhibitors and rational design of a covalent ARAF-MEK inhibitor. | bioRxiv | 2025 | 41446094 | PubTator, text mining | PubMed |
| Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies. | Res Sq | 2025 | 41282105 | PubTator, text mining | PubMed |
| DA-Raf synergistically binds to the plasma membrane and Ras to suppress ERK signaling. | Life Sci Alliance | 2025 | 41120211 | PubTator, text mining | PubMed |
| Characterization and inhibitor sensitivity of ARAF, BRAF, and CRAF kinases. | J Biol Chem | 2025 | 41072765 | PubTator, text mining | PubMed |
| Deciphering and targeting oncogenic pathways through integrated approaches and amino acid metabolism in hematologic malignancies. | Discov Oncol | 2025 | 40956459 | PubTator, text mining | PubMed |
| An in vitro BRAF activation assay elucidates molecular mechanisms driving disassembly of the autoinhibited BRAF state. | Proc Natl Acad Sci U S A | 2025 | 40953270 | PubTator, text mining | PubMed |
| Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling Simulations. | J Phys Chem B | 2025 | 40905485 | PubTator, text mining | PubMed |
| Prediction of cellular morphology changes under perturbations with a transcriptome-guided diffusion model. | Nat Commun | 2025 | 40897731 | PubTator, text mining | PubMed |
| Potential role of immune-related LncRNAs in prognosis of hepatocellular carcinoma: an integrative study. | Discov Oncol | 2025 | 40887519 | PubTator, text mining | PubMed |
| Clinical utility of liquid biopsy next-generation sequencing for advanced non-small cell lung cancer in the Netherlands. | Sci Rep | 2025 | 40830613 | PubTator, text mining | PubMed |
| Oncogenic Activity and Sorafenib Sensitivity of ARAF p.S214C Mutation in Lung Cancer. | Cancers (Basel) | 2025 | 40647542 | PubTator, text mining | PubMed |
| UPF3B Accelerates the Growth of Liver Cancer Cells by Enhancing Autophagy via CDK12. | Cell Biol Int | 2025 | 40637141 | PubTator, text mining | PubMed |
| Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasms. | Blood Neoplasia | 2025 | 40453139 | PubTator, text mining | PubMed |
| Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases? | Cancers (Basel) | 2025 | 40149325 | PubTator, text mining | PubMed |
| Ras-MAPK pathway in patients with lupus nephritis. | Lupus Sci Med | 2025 | 40102014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=2